122
Participants
Start Date
November 30, 2018
Primary Completion Date
September 1, 2023
Study Completion Date
September 1, 2023
Ganetespib
Ganetespib dose during chemotherapy will be 150mg/m² (q3w) Ganetespib dose during maintenance treatment will be 100mg/m² (q1w)
Niraparib
Niraparib starting dose during maintenance treatment will be 200mg or 300mg depending on subject's body weight and subject neutrophil count (QD)
Carboplatin
In combination with Gemcitabine: Carboplatin dose will be AUC4 (q3w) In combination with Paclitaxel: Carboplatin dose will be AUC5 (q3w)
Paclitaxel
Paclitaxel dose will be 175mg/m² (q3w)
Gemcitabine
Gemcitabine dose will be 1000mg/m² (q3w, d1 \& d8)
UZLeuven, Leuven
Medical University of Innsbruck, Innsbruck
Universitätsmedizin Berlin Charité, Berlin
Centre de lutte contre le cancer Francois Baclesse, Caen
Fondazione IRCCS Istituto Nazionale dei tumori Milano, Milan
Universitätsklinikum Hamburg-Eppendorf, Hamburg
Azienda Ospedaliero Bologna, Bologna
Kliniken Essen Mitte, Evang. Huyssens- Stiftung/Knappschaft GmbH, Essen
Universitätsklinikum Bonn, Bonn
Centre anticancereux Leon Berard, Lyon
Assistance Publique Hôpitaux de Paris, Paris
Universitätsklinikum Dresden, Dresden
Università Cattolica del Sacro Cuore, Rome
European Commission
OTHER
Universitaire Ziekenhuizen KU Leuven
OTHER